PMID- 6198963
OWN - NLM
STAT- MEDLINE
DCOM- 19840229
LR  - 20131121
IS  - 0385-0684 (Print)
IS  - 0385-0684 (Linking)
VI  - 11
IP  - 1
DP  - 1984 Jan
TI  - [Current problems on interferon research].
PG  - 10-5
AB  - The Interferon is a biological response modifier (BRM) rather than a 
      antibio-chemotherapeutic substance. Or, in other words, it may be a member of 
      "hormonal immune interferon prostaglandin (HIIP)" multisystem in animal body. The 
      author wishes to pick up the problems on clinical researches of human interferons 
      (alpha, beta and gamma type) from the view point of BRM. So, main theme is the 
      optimal posology and combined method of interferons and other therapies in viral 
      diseases and especially on cancer patients.
FAU - Kishida, T
AU  - Kishida T
LA  - jpn
PT  - English Abstract
PT  - Journal Article
PL  - Japan
TA  - Gan To Kagaku Ryoho
JT  - Gan to kagaku ryoho. Cancer & chemotherapy
JID - 7810034
RN  - 0 (Interferon Inducers)
RN  - 0 (Interferon Type I)
RN  - 0 (Interleukin-2)
RN  - 82115-62-6 (Interferon-gamma)
RN  - 8N3DW7272P (Cyclophosphamide)
RN  - 9008-11-1 (Interferons)
SB  - IM
MH  - Animals
MH  - Cyclophosphamide/administration & dosage
MH  - Humans
MH  - Interferon Inducers
MH  - Interferon Type I/therapeutic use
MH  - Interferon-gamma/therapeutic use
MH  - *Interferons
MH  - Interleukin-2
MH  - Lymphoma/therapy
MH  - Mice
MH  - Research
EDAT- 1984/01/01 00:00
MHDA- 1984/01/01 00:01
CRDT- 1984/01/01 00:00
PHST- 1984/01/01 00:00 [pubmed]
PHST- 1984/01/01 00:01 [medline]
PHST- 1984/01/01 00:00 [entrez]
PST - ppublish
SO  - Gan To Kagaku Ryoho. 1984 Jan;11(1):10-5.